G蛋白偶联受体HCAR3与选择性激动剂复合物的结构揭示配体识别与选择性的分子基础
Structures of G-protein coupled receptor HCAR3 in complex with selective agonists reveal the basis for ligand recognition and selectivity
生物技术与制药领域的最新动态
Structures of G-protein coupled receptor HCAR3 in complex with selective agonists reveal the basis for ligand recognition and selectivity
Prolonged starvation deepens quiescence in Vasa2/Piwi1-expressing cells of a sea anemone
From pipeline to network: We need to redefine scientific success
The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination
A new path to spillover: MHC-II entry of influenza A viruses
Keybanc Upgrades Thermo Fisher Scientific (TMO) to 'Overweight' with Price Target of $750 | TMO Stock News - GuruFocus
Vega Investment Solutions Sells 11,414 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Standout drug approvals in 2025
AbbVie hands back phase 1 duties for chronic inflammation drug to partner OSE
10x Genomics $TXG Shares Bought by Jump Financial LLC - MarketBeat
Meet the Next Generation of Benchtop Sequencing Systems - Genetic Engineering and Biotechnology News
Kallyope heads to Phase 3 with migraine drug after mid-stage success
NeurIPS 2025: Altos Labs Wins Generalist Prize at Arc’s Virtual Cell Challenge - Genetic Engineering and Biotechnology News
KeyBanc Upgrades Thermo Fisher Scientific to Overweight From Sector Weight, Price Target is $750 - marketscreener.com
Unifying life sciences insights to accelerate enterprise value
2026: The year AI’s role in pharma shifts from analysis to action
How digital companion apps unlock value across the drug lifecycle
Agilent and Monash University Malaysia to set up biodiscovery hub - Yahoo
Cerity Partners LLC Sells 2,142 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Is 10x Genomics Stock Built to Withstand More Downside? - Trefis